Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
David B Goldston, John F Curry, Karen C Wells, Yifrah Kaminer, Stephanie S Daniel, Christianne Esposito-Smythers, Otima Doyle, Jeffrey Sapyta, Angela M Tunno, Nicole C Heilbron, Michelle Roley-Robert. Feasibility of an Integrated Treatment Approach for Youth with Depression, Suicide Attempts, and Substance Use Problems. Evidence-based practice in child and adolescent mental health vol 6 issue 2 2022 35692895 |
reductions in alcohol and marijuana problems were similar, but half of the youth in tau alone (and none in the cbt-rp + tau group) had emergency department visits related to psychiatric crises or substance related problems. |
2022-06-13 |
2022-06-14 |
Not clear |
Soha Alali, Gholamhossein Riazi, Mohammad Reza Ashrafi-Kooshk, Sogol Meknatkhah, Shahin Ahmadian, Mohammad Hooshyari Ardakani, Baharak Hosseinkhan. Cannabidiol Inhibits Tau Aggregation In Vitro. Cells vol 10 issue 12 2021 34944028 |
cannabidiol inhibits tau aggregation in vitro. |
2021-12-24 |
2022-01-13 |
Not clear |
Kate Walsh, Amanda K Gilmore, Patricia Frazier, Linda Ledray, Ron Acierno, Kenneth J Ruggiero, Dean G Kilpatrick, Heidi S Resnic. A Randomized Clinical Trial Examining the Effect of Video-Based Prevention of Alcohol and Marijuana Use Among Recent Sexual Assault Victims. Alcoholism, clinical and experimental research vol 41 issue 12 2018 28940320 |
this study examined whether a brief video intervention (prevention of post-rape stress [pprs]) delivered in the emergency department to recent sexual assault (sa) victims reduced alcohol and marijuana use at 3 points over the course of a 6-month follow-up compared to treatment as usual (tau) and an active control condition (pleasant imagery and relaxation instruction [piri]). |
2018-07-18 |
2022-01-13 |
Not clear |
Tim Karl, Brett Garner, David Chen. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease. Behavioural pharmacology vol 28 issue 2 and 3-Spec Issue 2018 27471947 |
the phytocannabinoid cannabidiol (cbd) possesses neuroprotective, antioxidant and anti-inflammatory properties and reduces amyloid-\xce\xb2 production and tau hyperphosphorylation in vitro. |
2018-01-11 |
2022-01-12 |
Not clear |
Maria J Casarejos, Juan Perucho, Ana Gomez, Maria P Mu\\xc3\\xb1oz, Marian Fernandez-Estevez, Onintza Sagredo, Javier Fernandez Ruiz, Manuel Guzman, Justo Garcia de Yebenes, Maria A Men. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. Journal of Alzheimer's disease : JAD vol 35 issue 3 2013 23478312 |
we tested the effects of sativex\xc2\xae, a mixture of \xce\x949-tetrahydrocannabinol and cannabidiol, acting on both cb1 and cb2 receptors, in parkin-null, human tau overexpressing (pk-/-/tauvlw) mice, a model of complex frontotemporal dementia, parkinsonism, and lower motor neuron disease. |
2013-10-17 |
2022-01-12 |
Not clear |
Giuseppe Esposito, Daniele De Filippis, Rosa Carnuccio, Angelo A Izzo, Teresa Iuvon. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. Journal of molecular medicine (Berlin, Germany) vol 84 issue 3 2006 16389547 |
the marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through wnt/beta-catenin pathway rescue in pc12 cells. |
2006-08-30 |
2022-01-12 |
Not clear |
Giuseppe Esposito, Daniele De Filippis, Rosa Carnuccio, Angelo A Izzo, Teresa Iuvon. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. Journal of molecular medicine (Berlin, Germany) vol 84 issue 3 2006 16389547 |
here, we report that cannabidiol inhibits hyperphosphorylation of tau protein in abeta-stimulated pc12 neuronal cells, which is one of the most representative hallmarks in ad. |
2006-08-30 |
2022-01-12 |
Not clear |
D V Ary, E Lichtenstein, H H Severso. Smokeless tobacco use among male adolescents: patterns, correlates, predictors, and the use of other drugs. Preventive medicine vol 16 issue 3 1987 3588577 |
smokeless tobacco use was related to the use of other drugs, with 83% of male daily users indicating concurrent use of alcohol, marijuana, and/or cigarettes (tau = 0.354, 0.210, and 0.284, respectively). |
1987-07-08 |
2022-01-10 |
Not clear |